AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Functional Inspiratory Training in Bronchiectasis

RecruitingNAAges 18 Years - 30 YearsAllElif Kabasakal
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Bronchiectasis is a chronic respiratory disease clinically characterized by recurrent pulmonary exacerbations, chronic cough, and sputum production, and is associated with an increase in the airway-artery ratio and permanent airway dilatation. It is recognized as the third most common chronic respiratory disease after chronic obstructive pulmonary disease (COPD) and asthma. In the International Classification of Diseases and Related Health Problems (ICD-10), it has its own diagnostic code (J47.9). In bronchiectasis, mucociliary clearance is impaired due to bronchial dilatation, and the insufficient clearance of bacteria and mucus from the respiratory tract leads to persistent infection, inflammation, and further airway damage. Progressive airway damage results in impaired lung function, worsening of symptoms, and, ultimately, respiratory failure and death. It can represent the final pat

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 30 years * Diagnosed with bronchiectasis * Clinically stable * Able to cooperate * Able to walk independently * Volunteering to participate in the study Exclusion Criteria: * History of acute exacerbation and/or hospitalization within the past 4 weeks * Change in medical treatment within the past month * Known diagnosed conditions affecting balance (visual, auditory, vestibular, or musculoskeletal disorders) * Participation in a supervised physiotherapy rehabilitation program within the past 6 months * History of lung or liver transplantation
๐Ÿ’Š

What it tests

  • Functional Inspiratory Muscle Training (FIMT)
  • Inspiratory Muscle Training (IMT)
๐Ÿ“

Where

1 site
Istinye University, Istanbul,
Istanbul, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy